Mikrogen Diagnostik recomWell Yersinia IgA ELISA Kit (4606)
$350.00
| Host | Quantity | Applications | Species Reactivity | Data Sheet | |
|---|---|---|---|---|---|
| 96 Tests | ELISA | Yersinia |  |
Overview
Product Name Mikrogen Diagnostik recomWell Yersinia IgA ELISA Kit (4606)
Description Enzyme immunoassay with recombinant antigens for the detection of IgG, IgA or IgM antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis.
Target Human Yersinia IgA
Species Reactivity Yersinia
Assay Type Indirect ELISA
Applications ELISA
Properties
Background In the past years, Yersinia enterocolitica has become increasingly important as an intestinal bacterium that is pathogenic for human beings. This organism is transmitted orally by contaminated water or food. Typical symptoms of an acute Yersinia infection are diarrhoea, stomach ache, and fever.
Complications such as reactive arthritis, erythema nodosum and other rheumatic diseases can occur, especially with HLA-B27 carriers. These patients typically show high and persistent IgA titers against Yersinia antigens.
recomWell Yersinia tests are quantitative in vitro tests for the detection and safe identification of antibodies against plasmid-coded virulence proteins. The antigens (YOPs - Yersinia outer membrane proteins) used in these tests are expressed only by strains of Yersinia that are pathogenic for human beings.
The use of recombinant antigens guarantees optimum representation of the immundominant YOPs in the absence of cross-reacting proteins. As a second major advantage, the clarification of Yersinia induced reactive arthritis is supproted by separate detection of antibody classes IgG, IgA and IgM.
Complications such as reactive arthritis, erythema nodosum and other rheumatic diseases can occur, especially with HLA-B27 carriers. These patients typically show high and persistent IgA titers against Yersinia antigens.
recomWell Yersinia tests are quantitative in vitro tests for the detection and safe identification of antibodies against plasmid-coded virulence proteins. The antigens (YOPs - Yersinia outer membrane proteins) used in these tests are expressed only by strains of Yersinia that are pathogenic for human beings.
The use of recombinant antigens guarantees optimum representation of the immundominant YOPs in the absence of cross-reacting proteins. As a second major advantage, the clarification of Yersinia induced reactive arthritis is supproted by separate detection of antibody classes IgG, IgA and IgM.
Sample Type Serum, plasma, whole blood
Assay Resolution See Figure
Components
| 10X Wash Buffer | 100 mL |
| Dilution Buffer | 125 mL |
| TMB Substrate | 12 mL |
| Stop Slution | 12 mL |
| Instuctions for Use | 1 Each |
| Evaluation Form | 1 Each |
| Microplate Sealing Tape | 2 Each |
| Microtiter Plate | 12 x 8 Wells |
| Positive Control | 450 uL |
| Cut-Off Control | 450 uL |
| Negative Control | 450 uL |
| Anti-Human IgA Conjugate | 500 uL |
Specificity Information
Target Name Yersinia
Target ID Human Yersinia IgA
Alternative Names Yersinia
Research Areas Infectious Disease
Application Images
Description Test Principle
Description Evaluation
Additional Information
Additional Information Additional Mirkogen Kit Information
Handling
Storage Store at 2 - 8°C until expiration on packaging.
References & Data Sheet
Data Sheet 
Download PDF Data Sheet
Download PDF Data Sheet